ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/04/2026
Voltar para busca
Dado oficial do USPTO
ALKERMES
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
ALKERMES
ST13
US500000088788969Classe
5, 35, 36, 44, 45
Pedido
88788969
Registro
6925355
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
39
Atualização mais recente
25/04/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 35, 36, 44, 45
Data de depósito
07/02/2020
Data de registro
13/12/2022
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
13/12/2022
Última transação
25/04/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Primeiro uso
21/01/2022
Primeiro uso no comércio
21/01/2022
Código do desenho
4
Tipo de titular
03
Localização do titular
Waltham, MA, US
Examinador
DANG, PETER T
Unidade examinadora
N30
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Alkermes, Inc.
Representantes
Norm J. Rich FOLEY & LARDNER LLP
Classificação técnica
Classes Nice
Classe 5Classe 35Classe 36Classe 44Classe 45
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparationscompounds for use in treating addictionsubstance abuse and dependencediseases and disorders of the central nervous systemcancerreward disorderspsychiatric and neurodegenerative diseases and disorders in the nature of schizophreniadepressionmajor depressive disorderstressanxietytreatment resistant depressionbipolar depressionbipolar disorder; pharmaceutical preparations for use in treating cardiovascular diseases and metabolic diseases; pharmaceutical preparations for the mitigation of weight gain and the treatment of metabolic diseases and dyslipidaemia; Pharmaceutical preparationsprodrugs and chemical derivatives of pharmaceutically active ingredients for the treatment of central nervous system diseases and disorderspsychiatric and neurodegenerative diseasescardiovascular diseases and metabolic diseases; pharmaceutical preparations in the nature of compoundssmall molecules and chemical compounds for use in opioid modulation for treating opioid use disorders
Classe 35
Administration and management of an annual competitive award program in the nature of research grants for scientific research; Logistics management in the field of medicationbusiness services in the nature of supporting the coordination of medication delivery to avoid product delivery delays; providing business administration information to patients and health care providers about medication reimbursement options regarding reimbursement procedures; providing information about pharmaceutical servicesproviding information about processing online prescription orders in retail pharmacies regarding pharmacy authorization in the nature of prescription fulfillment and approval instructions for delivery of medication in the nature of accepting payment terms; appointment reminder services being support services for patients and for health care providers on behalf of their patients
Classe 36
Providing grants to organizations dedicated to patient focused medical research; funding service awardsproviding grants to patient advocacy groups and institutions for the treatment and management of diseases includingbut not limited toaddiction and central nervous system disorders; Providing insurance information about pharmaciesproviding a database featuring information about insurance coverage for pharmaceuticals in the nature of pharmacy selection based on patient health plan coverage requirements; providing insurance information about pharmaceutical coverage by patient health plans; providing insurance administration information to patients and health care providers about medication reimbursement options; insurance servicesinsurance eligibility review and verification being support services for patients and for health care providers on behalf of their patientsproviding health benefit verification services to determine coverage of medication treatment in the health industry; financial administration of medication reimbursement programs being support services for patients and for health care providers on behalf of their patientscoordinating medication reimbursement programs
Classe 44
Providing educational information in the field of medication treatment to health care providers and patients; providing educational information about pharmaceutical products relating to diagnosticprophylactic and therapeutic properties of pharmaceuticals
Classe 45
Support services for health care providers and their patients in the nature of providing patient advocate and case management servicescoordinating the procurement of medication in the nature of coordinating with pharmacies to facilitate prescription fulfillment; providing patient advocate and case management services in the nature of support services for patients and for health care providers on behalf of their patientscoordinating the procurement and administration of medication in the nature of locating health care providers that can prescribe and/or administer prescribed medication
Publicações
Histórico de despachos e eventos da marca no USPTO.
39 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
13/12/2022
R.PR
REGISTERED-PRINCIPAL REGISTER
13/12/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
09/11/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
08/11/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/11/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
07/11/2022
EX4G
SOU EXTENSION 4 GRANTED
07/11/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
07/11/2022
IUAF
USE AMENDMENT FILED
28/10/2022
EXT4
SOU EXTENSION 4 FILED
28/10/2022
EEXT
SOU TEAS EXTENSION RECEIVED
28/10/2022
EISU
TEAS STATEMENT OF USE RECEIVED
28/10/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
07/05/2022
EX3G
SOU EXTENSION 3 GRANTED
05/05/2022
EXT3
SOU EXTENSION 3 FILED
05/05/2022
EEXT
SOU TEAS EXTENSION RECEIVED
05/05/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
18/11/2021
EX2G
SOU EXTENSION 2 GRANTED
16/11/2021
EXT2
SOU EXTENSION 2 FILED
16/11/2021
EEXT
SOU TEAS EXTENSION RECEIVED
16/11/2021
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
01/05/2021
EX1G
SOU EXTENSION 1 GRANTED
29/04/2021
EXT1
SOU EXTENSION 1 FILED
29/04/2021
EEXT
SOU TEAS EXTENSION RECEIVED
29/04/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
17/11/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
22/09/2020
PUBO
PUBLISHED FOR OPPOSITION
22/09/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/09/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
17/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
07/08/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/08/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/08/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
28/04/2020
GNRT
NON-FINAL ACTION E-MAILED
28/04/2020
CNRT
NON-FINAL ACTION WRITTEN
28/04/2020
DOCK
ASSIGNED TO EXAMINER
28/04/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/02/2020
NWAP
NEW APPLICATION ENTERED
11/02/2020
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace ALKERMES ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.